Novartis (NVS)
(Delayed Data from NYSE)
$110.32 USD
+0.39 (0.35%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $110.30 -0.02 (-0.02%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth A Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 10/22/24 |
---|---|
Current Quarter | 1.88 |
EPS Last Quarter | 1.97 |
Last EPS Surprise | 5.35% |
ABR | 2.57 |
Earnings ESP
|
3.60% |
---|---|
Current Year | 7.37 |
Next Year | 8.23 |
EPS (TTM) | 7.04 |
P/E (F1) | 14.96 |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 12.35B | 12.59B | 49.38B | 52.39B |
# of Estimates | 4 | 4 | 4 | 4 |
High Estimate | 12.50B | 12.78B | 50.63B | 54.52B |
Low Estimate | 12.14B | 12.44B | 48.50B | 51.51B |
Year ago Sales | 11.78B | 11.42B | 49.78B | 49.38B |
Year over Year Growth Est. | 4.80% | 10.22% | -0.80% | 6.10% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.88 | 1.82 | 7.37 | 8.23 |
# of Estimates | 4 | 3 | 7 | 7 |
Most Recent Consensus | 1.84 | 1.79 | 7.50 | 8.15 |
High Estimate | 1.96 | 1.91 | 7.59 | 8.82 |
Low Estimate | 1.78 | 1.76 | 7.15 | 7.60 |
Year ago EPS | 1.74 | 1.53 | 6.90 | 7.37 |
Year over Year Growth Est. | 8.05% | 18.95% | 6.81% | 11.61% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 1 | 1 |
Up Last 30 Days | 0 | 0 | 3 | 2 |
Up Last 60 Days | 1 | 1 | 4 | 3 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 0 | 1 | 1 |
Down Last 60 Days | 1 | 0 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 1.88 | 1.82 | 7.37 | 8.23 |
7 Days Ago | 1.88 | 1.82 | 7.37 | 8.21 |
30 Days Ago | 1.86 | 1.82 | 7.29 | 8.20 |
60 Days Ago | 1.86 | 1.82 | 7.28 | 8.20 |
90 Days Ago | 1.86 | 1.81 | 7.27 | 8.16 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 1.95 | 1.82 | 7.52 | 8.44 |
Zacks Consensus Estimate | 1.88 | 1.82 | 7.37 | 8.23 |
Earnings ESP | 3.60% | 0.00% | 1.93% | 2.57% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 1.97 | 1.80 | 1.53 | 1.74 | NA |
Estimate | 1.87 | 1.73 | 1.64 | 1.70 | NA |
Difference | 0.10 | 0.07 | -0.11 | 0.04 | 0.03 |
Surprise | 5.35% | 4.05% | -6.71% | 2.35% | 1.26% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more